Swiss National Bank’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.4M Buy
203,700
+9,400
+5% +$249K ﹤0.01% 1252
2025
Q1
$4.69M Sell
194,300
-1,900
-1% -$45.9K ﹤0.01% 1299
2024
Q4
$7.9M Buy
196,200
+2,400
+1% +$96.6K 0.01% 1060
2024
Q3
$12.3M Buy
193,800
+200
+0.1% +$12.7K 0.01% 840
2024
Q2
$10.3M Buy
193,600
+25,000
+15% +$1.33M 0.01% 898
2024
Q1
$13.8M Buy
168,600
+1,000
+0.6% +$82K 0.01% 768
2023
Q4
$3.12M Sell
167,600
-29,900
-15% -$556K ﹤0.01% 1590
2023
Q3
$2.19M Sell
197,500
-8,500
-4% -$94.1K ﹤0.01% 1784
2023
Q2
$3.34M Buy
206,000
+39,100
+23% +$634K ﹤0.01% 1563
2023
Q1
$2.78M Buy
+166,900
New +$2.78M ﹤0.01% 1630
2022
Q2
Sell
-166,500
Closed -$500K 2794
2022
Q1
$500K Buy
166,500
+11,200
+7% +$33.6K ﹤0.01% 2606
2021
Q4
$714K Hold
155,300
﹤0.01% 2579
2021
Q3
$975K Buy
155,300
+10,100
+7% +$63.4K ﹤0.01% 2448
2021
Q2
$870K Sell
145,200
-4,800
-3% -$28.8K ﹤0.01% 2528
2021
Q1
$949K Buy
150,000
+3,000
+2% +$19K ﹤0.01% 2360
2020
Q4
$828K Hold
147,000
﹤0.01% 2367
2020
Q3
$856K Hold
147,000
﹤0.01% 2168
2020
Q2
$1.06M Buy
147,000
+22,600
+18% +$163K ﹤0.01% 2067
2020
Q1
$582K Hold
124,400
﹤0.01% 2116
2019
Q4
$998K Buy
124,400
+4,800
+4% +$38.5K ﹤0.01% 2140
2019
Q3
$823K Hold
119,600
﹤0.01% 2155
2019
Q2
$993K Buy
119,600
+2,400
+2% +$19.9K ﹤0.01% 2113
2019
Q1
$1.17M Buy
117,200
+5,600
+5% +$55.7K ﹤0.01% 1988
2018
Q4
$854K Buy
+111,600
New +$854K ﹤0.01% 2092